Spectrum of conditionally pathogenic microflora isolated from the prostate secret in chronic bacterial prostatitis patients
https://doi.org/10.12737/article_5a3a0dd8cfc440.60849200
Abstract
The article represents a description for microbiocenosis of isolated prostate secret. The initial samples were taken on the territory of the Irkutsk region from men diagnosed with chronic bacterial prostatitis in the acute stage. 90 % of samples of isolated prostate secret were tested by cultural method revealed 4l representatives of opportunistic pathogenic microflora. Gram-positive microorganisms were found in most samples (86.7 %). Staphylococcus genus representatives formed the majority in isolated samples of conditionally pathogenic microflora (66.7 %). As for gram-negative representatives (which role in chronic bacterial prostatitis is proven by multiple research), E. coli and K. pneumoniae were isolated. In the half of samples, we revealed bacterial associations consisting mostly of two kinds of microorganisms. Staphylococcus epidermidis was isolated in 70 % of such associations.
About the Authors
T. V. Tunik
Scientific Centre for Family Health and Human Reproduction Problems
Russian Federation
Russian Federation
E. I. Ivanova
Scientific Centre for Family Health and Human Reproduction Problems
Russian Federation
Russian Federation
E. V. Grigorova
Scientific Centre for Family Health and Human Reproduction Problems
Russian Federation
Russian Federation
N. M. Voropayeva
Scientific Centre for Family Health and Human Reproduction Problems
Russian Federation
Russian Federation
V. A. Vishnevskaya
Scientific Centre for Family Health and Human Reproduction Problems
Russian Federation
Russian Federation
References
1. Аляев Ю.Г., Шпоть Е.В., Султанова Е.А. Хронический простатит: оптимизация подходов к лечению // РМЖ. Урология. - 2011. - № 29. - С. 1-6
2. Коган М.И., Ибишев Х.С., Набока Ю.Л., Ферзаули А.Х. Микробные патогены при хроническом бактериальном простатите // Медицинский вестник Башкортостана. - 2011. - Т. 6, № 2. - С. 104-106
3. Локшин К.Л. Актуальные вопросы этиологии, эпидемиологии и лечения острого и хронического бактериального простатита - новые данные на 2013 год // Эффективная фармакотерапия. -2013.-№16.-С. 34-43
4. Лопаткин Н.А., Сивков А.В., Аполихин О.И. Хронический простатит [Электронный ресурс]. - М., 2004
5. Набер К.Г., Сухорукова М.В. Микробиологические аспекты диагностики хронического простатита // Клиническая микробиология и антимикробная химиотерапия. - 2006. - Т. 8, № 1. - С. 4-17
6. Набока Ю.Л., Коган М.И., Черницкая М.Л., Гудима И.А., Ибишев Х.С., Ферзаули А.Х. Микробный спектр секрета предстательной железы и факторы персистенции бактерий, обнаруженных при хроническом бактериальном простатите // Бюллетень Оренбургского научного центра УрО РАН (электронный журнал). - 2012. № 3. - С. 2-6
7. Степенский А.Б., Попов С.В., Муфагед М.Л. Диагностика и лечение хронического простатита // Consilium medicum. - 2003. - Т. 5, № 7. - С. 396-401
8. Шангичев А.В., Набока Ю.Л., Ибишев Х.С., Коган М.И. Микробный спектр и антибиотикочувствительность микрорганизмов секрета простаты при хроническом бактериальном простатите // Кубанский научный медицинский вестник. - 2010. -№ 3-4. - С. 117-118
9. Щеплев П.А. Простатит. - М.: МЕДпресссинформ, 2007. - 224 с
10. Alexander RB. (2004). Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome. Ann Intern Med, 141 (8), 581-589.
11. Bundrick W, Heron SP, Ray P. (2003). Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study. Urology, 62 (537), 41.
12. Krieger JN. (2004). Classification, epidemiology and implications of chronic prostatitis in North America, Europe and Asia. Minerva UrolNefrol, 56 (99), 107.
13. Naber KG. (2002). Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis. Int J Antimicrob Agents, 20 (18), 27.
14. Naber KG, Busch W, Focht J. (2000). Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up. The German Prostatitis Study Group. Int J Antimicrob Agents, 14 (143), 9.
15. Nagy V, Kubej D. (2012). Acute bacterial prostatitis in humans: current microbiological spectrum, sensitivity to antibiotics and clinical findings. Urol Int, 89 (4), 445-450.
16. Nickel JC, Alexander RB, Schaeffer AJ. (2003). Leukocytes and bacteria in men with chronic prostatitis/ chronic pelvic pain syndrme compared to asymptomatic controls. Urology, 170 (818), 22.
17. Nickel JC, McNaughton-Collins М, Litwin MS. (2001). Development and use of a validated outcome measure for chronic prostatitis. JCOM, 8 (l), 30-37
18. Nickel JC, Moon T. (2005). Chronic bacterial prostatitis: an evolving clinical enigma. Urology, 66 (2), 8.
19. Roberts RO, Jacobson DJ, Girman CJ. (2002). Prevalence of prostatitis-like symptoms in a community based cohort of older men. Urology, 168 (2467), 71.
20. Shoskes DA. (2008). Chronic prostatitis/chronic pelvic pain syndrome. Humana Press, 31-45.
Review
For citations:
Tunik T.V., Ivanova E.I., Grigorova E.V., Voropayeva N.M., Vishnevskaya V.A. Spectrum of conditionally pathogenic microflora isolated from the prostate secret in chronic bacterial prostatitis patients. Acta Biomedica Scientifica. 2017;2(5(2)):70-73. (In Russ.) https://doi.org/10.12737/article_5a3a0dd8cfc440.60849200
Views:
1489
Email this article 
